Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Digestive Diseases and Sciences
|
June 7, 2008
A risk profile for advanced proximal neoplasms on diagnostic colonoscopy
Thomas M Zarchy, Frank Tsai, Emily Ramicone, et al.
Biomedical Microdevices
|
August 4, 2009
Microfluidic cell sorter with integrated piezoelectric actuator
Chun H Chen, Sung Hwan Cho, Frank Tsai, et al.
Journal of Biophotonics
|
April 4, 2009
Microfluidics and photonics for Bio-System-on-a-Chip: a review of advancements in technology towards a microfluidic flow cytometry chip
Jessica Godin, Chun-Hao Chen, Sung Hwan Cho, et al.
Analytical Chemistry
|
August 4, 2011
Specific sorting of single bacterial cells with microfabricated fluorescence-activated cell sorting and tyramide signal amplification fluorescence in situ hybridization
Chun H Chen, Sung H Cho, Hsin-I Chiang, et al.
Cancers
|
April 14, 2025
Immersive Virtual Reality for Enabling Patient Experience and Enrollment in Oncology Clinical Trials: A Feasibility Study
Frank Tsai, Landon Gray, Amy Mirabella, et al.
Cancer
|
February 15, 2013
A phase 1 study of everolimus plus docetaxel plus cisplatin as induction chemotherapy for patients with locally and/or regionally advanced head and neck cancer
Matthew G Fury, Eric Sherman, Alan L Ho, et al.
Plos One
|
December 20, 2016
Outcomes of Phacoemulsification Using Different Size of Clear Corneal Incision in Eyes with Previous Radial Keratotomy
Jing Shang Zhang, Xue Liu, Jin Da Wang, et al.
Cancer Chemotherapy and Pharmacology
|
June 22, 2018
A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancer
Amita Patnaik, Michael Gordon, Frank Tsai, et al.
Cancer Chemotherapy and Pharmacology
|
July 18, 2018
Correction to: A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancer
Amita Patnaik, Michael Gordon, Frank Tsai, et al.
Investigational New Drugs
|
May 20, 2024
Correction to: CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial
Andrew J Armstrong, Ravit Geva, Hyun Cheol Chung, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Digestive Diseases and Sciences
|
June 7, 2008
A risk profile for advanced proximal neoplasms on diagnostic colonoscopy
Thomas M Zarchy, Frank Tsai, Emily Ramicone, et al.
Biomedical Microdevices
|
August 4, 2009
Microfluidic cell sorter with integrated piezoelectric actuator
Chun H Chen, Sung Hwan Cho, Frank Tsai, et al.
Journal of Biophotonics
|
April 4, 2009
Microfluidics and photonics for Bio-System-on-a-Chip: a review of advancements in technology towards a microfluidic flow cytometry chip
Jessica Godin, Chun-Hao Chen, Sung Hwan Cho, et al.
Analytical Chemistry
|
August 4, 2011
Specific sorting of single bacterial cells with microfabricated fluorescence-activated cell sorting and tyramide signal amplification fluorescence in situ hybridization
Chun H Chen, Sung H Cho, Hsin-I Chiang, et al.
Cancers
|
April 14, 2025
Immersive Virtual Reality for Enabling Patient Experience and Enrollment in Oncology Clinical Trials: A Feasibility Study
Frank Tsai, Landon Gray, Amy Mirabella, et al.
Cancer
|
February 15, 2013
A phase 1 study of everolimus plus docetaxel plus cisplatin as induction chemotherapy for patients with locally and/or regionally advanced head and neck cancer
Matthew G Fury, Eric Sherman, Alan L Ho, et al.
Plos One
|
December 20, 2016
Outcomes of Phacoemulsification Using Different Size of Clear Corneal Incision in Eyes with Previous Radial Keratotomy
Jing Shang Zhang, Xue Liu, Jin Da Wang, et al.
Cancer Chemotherapy and Pharmacology
|
June 22, 2018
A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancer
Amita Patnaik, Michael Gordon, Frank Tsai, et al.
Cancer Chemotherapy and Pharmacology
|
July 18, 2018
Correction to: A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancer
Amita Patnaik, Michael Gordon, Frank Tsai, et al.
Investigational New Drugs
|
May 20, 2024
Correction to: CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial
Andrew J Armstrong, Ravit Geva, Hyun Cheol Chung, et al.
Page
of 2